Literature DB >> 11709614

Central nervous system complications in two cases of juvenile onset dermatomyositis.

A V Ramanan1, S Sawhney, K J Murray.   

Abstract

Central nervous system (CNS) complications are rarely reported in either juvenile or adult onset inflammatory myositides, such as dermatomyositis and polymyositis. We report two children, aged 4 and 10 yr respectively, with a diagnosis of juvenile dermatomyositis, both of whom subsequently developed clinical features of severe CNS involvement, possibly consistent with cerebral vasculopathy. One child died from apparent brainstem involvement; the other developed seizures, pseudoseizures and clinical depression which responded to aggressive immunosuppression. Although the vasculopathy or vasculitis underlying this disorder is known to have a systemic distribution, CNS involvement has rarely been reported and may be under-recognized.

Entities:  

Mesh:

Year:  2001        PMID: 11709614     DOI: 10.1093/rheumatology/40.11.1293

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  8 in total

1.  Anti-MDA5 antibody-positive dermatomyositis with mild encephalopathy with reversible splenial lesion: a possible rare association?

Authors:  Khadija Saghir; Mohammed Chraa; Najib Kissani; Hajar Joulal; Lamiaa Essaadouni; Nissrine Louhab
Journal:  Wien Med Wochenschr       Date:  2022-06-21

2.  Multiple symptoms of higher brain dysfunction caused by Marchiafava-Bignami disease in a patient with dermatomyositis.

Authors:  Kanako Furukawa; Etsuko Maeshima; Shinichiro Maeshima; Masakazu Ichinose
Journal:  Rheumatol Int       Date:  2009-10-22       Impact factor: 2.631

3.  Major Depressive Disorder Following Dermatomyositis: A Case Linking Depression with Inflammation.

Authors:  Abhishek Reddy; Badari Birur; Richard C Shelton; Li Li
Journal:  Psychopharmacol Bull       Date:  2018-03-13

4.  Hemophagocytic lymphohistiocytosis with leukoencephalopathy in a patient with dermatomyositis accompanied with peripheral T-cell lymphoma: a case report.

Authors:  Satoru Teshigawara; Yoshinori Katada; Yuichi Maeda; Maiko Yoshimura; Eriko Kudo-Tanaka; Soichiro Tsuji; Yoshinori Harada; Masato Matsushita; Shiro Ohshima; Kotaro Watanabe; Takahiro Kumode; Yoshihiko Hoshida; Yukihiko Saeki
Journal:  J Med Case Rep       Date:  2016-08-02

Review 5.  Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools.

Authors:  Judith Wienke; Claire T Deakin; Lucy R Wedderburn; Femke van Wijk; Annet van Royen-Kerkhof
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

6.  Epilepsy as a Comorbidity in Polymyositis and Dermatomyositis-A Cross-Sectional Study.

Authors:  Ella Nissan; Abdulla Watad; Arnon D Cohen; Kassem Sharif; Johnatan Nissan; Howard Amital; Ora Shovman; Nicola Luigi Bragazzi
Journal:  Int J Environ Res Public Health       Date:  2021-04-10       Impact factor: 3.390

7.  Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling.

Authors:  Claire T Deakin; Raquel Campanilho-Marques; Stefania Simou; Elena Moraitis; Lucy R Wedderburn; Eleanor Pullenayegum; Clarissa A Pilkington
Journal:  Arthritis Rheumatol       Date:  2018-03-25       Impact factor: 10.995

Review 8.  The Vasculopathy of Juvenile Dermatomyositis.

Authors:  Charalampia Papadopoulou; Liza J McCann
Journal:  Front Pediatr       Date:  2018-10-09       Impact factor: 3.418

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.